Yoshiyuki Nakamura

60PUBLICATIONS
80CO-AUTHORS
NanomedicineMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Mar 04, 2024
Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.

Kazumasa Oya, Yoshiyuki Nakamura, Larina Tzu-Wei Shen

|Feb 02, 2024
Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.

Yue Zhang, Vanthana Bharathi, Tatsuya Dokoshi

|Jul 14, 2023
Role of Sentinel Lymph Node Biopsy for Skin Cancer Based on Clinical Studies.

Shoichiro Ishizuki, Yoshiyuki Nakamura

|Aug 12, 2022
Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.

Shoichiro Ishizuki, Yoshiyuki Nakamura

|May 05, 2022
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).

Anna Kamimura, Yasuhiro Nakamura, Tatsuya Takenouchi

Pageof 10

Frequent Collaborators

39 joint publications

Yasuhiro Fujsawa

34 joint publications

Naoko Okiyama

27 joint publications

Rei Watanabe

18 joint publications

Yosuke Ishitsuka